Company Overview and News

1
Top Analyst Reports for IBM, Enbridge & ADP

2018-04-12 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including IBM (IBM), Enbridge (ENB) and ADP (ADP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Upvote Downvote

 
4 Canadian ideas for using captured carbon reach XPrize finals

2018-04-09 cbc.ca
A $20 million international competition to make profitable products from a gas that otherwise would contribute to global warming has entered its final stretch.
Upvote Downvote

 
Pollution to products: CO2 competition enters final round

2018-04-09 nzherald.co.nz
CHEYENNE, Wyo. (AP) — A $20 million international competition to make profitable products from a gas that otherwise would contribute to global warming has entered its final stretch.
Upvote Downvote

 
NRG / NRG Energy, Inc. DEFA14A

2018-04-05 sec.gov
QuickLinks -- Click here to rapidly navigate through this document
Upvote Downvote

 
NRG Energy (NRG) Up 13.4% Since Earnings Report: Can It Continue?

2018-04-02 zacks
It has been about a month since the last earnings report for NRG Energy, Inc. (NRG - Free Report) . Shares have added about 13.4% in that time frame.
Upvote Downvote

 
These 5 S&P 500 Utilities Offer Up to 20% Potential Upside

2018-03-26 editors.aws.marketrealist
In this part of our series, we’ll take a look at S&P 500 Utilities (XLU) stocks that offer attractive upside potential.
Upvote Downvote

 
Volatility Trends: Utilities versus the Broader Markets

2018-03-26 editors.aws.marketrealist
Implied volatility in broader markets significantly increased, close to 19%, last week, mainly on the lines of trade war prospects. In comparison, implied volatility in the Utilities Select Sector SPDR ETF (XLU) was 16%, which was higher than its 15-day average volatility.
Upvote Downvote

1
Stocks To Watch: Back To School For Apple

2018-03-24 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

 
NRG / NRG Energy, Inc. 8-K (Current Report)

2018-03-22 sec.gov
UNITED STATES SECURITIES A
Upvote Downvote

 
NRG Energy's (NRG) Transformation Plan Propel It to New High

2018-03-16 zacks
NRG Energy (NRG - Free Report) has gained 70.4% in the last year against 4.4% decline of its industry. This Zacks Rank #3 (Hold) stock reported positive earnings surprise in two of the last four quarters, resulting in an average positive surprise of 374.24%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Upvote Downvote

 
Top Research Report for AT&T, Goldman Sachs & Sanofi

2018-03-15 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AT&T (T), Goldman Sachs (GS) and Sanofi (SNY). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Upvote Downvote

 
NRG / NRG Energy, Inc. DEF 14A

2018-03-15 sec.gov
Table of Contents
Upvote Downvote

 
NRG / NRG Energy, Inc. DEFA14A

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Upvote Downvote

 
NRG Energy Scales a 52-Week High on Transformation Plan

2018-03-13 zacks
NRG Energy, Inc. (NRG - Free Report) hit a new 52-week high of $30.11 before closing the session a bit lower at $29.89 on Mar 12. Year to date, the stock has delivered an impressive return of about 75.7% compared with the S&P 500 index’s rally of 18.0%. Over the past 52 weeks, NRG Energy’s shares have ranged from a low of $14.52 to a high of $30.11. Average volume of shares traded over the last three months is approximately 6.
Upvote Downvote

 
S&P 500 Utilities: Last Week’s Best and Worst Performers

2018-03-12 editors.aws.marketrealist
Investors seemed cautious about utilities last week, given the increased possibility of another interest rate hike in the Fed’s upcoming meeting. US Treasury yields continued to trade strong last week, and the ten-year Treasury yield closed at 2.90%, close to its four-year high. The Utilities Select Sector SPDR ETF (XLU) rose 1% while broader markets soared almost 4% last week.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 629377508